TP53 and breast carcinoma: The results demonstrated that elevated Twist1 expression combined with mutant p53 predicted shorter RFS for basal-like breast cancer patients (P = 0.027) (Figure 2G); however, there was no difference for the OS (P = 0.18) (Figure 3G).